financetom
Business
financetom
/
Business
/
Papa John's focused on executing its strategy but open to alternatives, CEO says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Papa John's focused on executing its strategy but open to alternatives, CEO says
Nov 6, 2025 6:33 AM

NEW YORK, Nov 6 (Reuters) - Papa John's CEO

Todd Penegor on Thursday said the U.S. pizza chain is focusing

on executing its strategy to drive value, but noted it would

consider alternatives if they were available.

Penegor, speaking in an earnings call after Papa John's missed

its third-quarter earnings estimates, promised a host of

improvements, including cost cuts and new side dishes and then

addressed what he called "M&A rumors" after Reuters reported

this week that a bid to take the company private had been

withdrawn.

He acknowledged that softer consumer spending is weighing on

quick-serve restaurants, but that the company is "positioning

Papa John's to compete better in 2026." He said it is working on

transforming the brand and fueling sustainable, profitable sales

growth in the future.

The company cut its 2025 sales outlook because it now

expects North American sales to be down 2% to 2.5% for the year,

after an earlier forecast of being flat to up 2%.

Private equity firm Apollo Global withdrew its

offer to take Papa John's private at $64 a share on concerns

about consumer sentiment and the pizza chain's ability to

navigate the weaker outlook, sources familiar with the matter

told Reuters. The deal would have valued the company at $2.1

billion.

Investors had hoped Penegor would address speculation about a

possible deal. He said if there were an alternative to the

company's strategy, management and the board would "fully

consider it."

Papa John's shares were down more than 5% in pre-market trading

after 5% and 10% drops on Wednesday and Tuesday, respectively.

The company's stock has dropped nearly 20% in the last five days

and is down 28% in the last 12 months.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amphastar Pharmaceuticals Insider Sold Shares Worth $672,815, According to a Recent SEC Filing
Amphastar Pharmaceuticals Insider Sold Shares Worth $672,815, According to a Recent SEC Filing
Dec 16, 2024
05:27 PM EST, 12/16/2024 (MT Newswires) -- Rong Zhou, Senior Executive Vice President, Production Center, on December 12, 2024, sold 15,000 shares in Amphastar Pharmaceuticals ( AMPH ) for $672,815. Following the Form 4 filing with the SEC, Zhou has control over a total of 223,137 shares of the company, with 118,469 shares held directly and 104,668 controlled indirectly. SEC...
CG Oncology Closes $238 Million Offering
CG Oncology Closes $238 Million Offering
Dec 16, 2024
05:28 PM EST, 12/16/2024 (MT Newswires) -- CG Oncology ( CGON ) said Monday it closed a $238 million public offering of 9.2 million shares at $28 apiece. The offering consists of 8.5 million shares sold by the company, inclusive of 1.2 million shares covered by the underwriters' option to purchase additional shares, and 700,000 shares sold by an existing...
GoDaddy Subsidiaries Complete $1.46 Billion Credit Agreement Refinancing
GoDaddy Subsidiaries Complete $1.46 Billion Credit Agreement Refinancing
Dec 16, 2024
05:29 PM EST, 12/16/2024 (MT Newswires) -- GoDaddy ( GDDY ) said late Monday its subsidiaries, Go Daddy Operating and GD Finance, closed a credit agreement refinancing. The proceeds from the new tranche of term loans of more than $1.46 billion, maturing in 2029, were used to refinance all outstanding debt under the so-called Existing Tranche B-6 Term Loans. The...
Quipt Home Medical Posts Wider Fourth-quarter Net Loss, Higher Revenue
Quipt Home Medical Posts Wider Fourth-quarter Net Loss, Higher Revenue
Dec 16, 2024
05:26 PM EST, 12/16/2024 (MT Newswires) -- Quipt Home Medical ( QIPT ) after trade Monday reported a wider fourth-quarter net loss despite higher revenue. The company said it lost US$3.2 million compared with US$1.3 million in the year-prior quarter. Revenue for the quarter ended Sept. 30 rose 3% to US$61.3 million from US$59.6 million. Sequential organic revenue growth was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved